This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2003 Dec;48(12):3308-19.

doi: 10.1002/art.11358.

Rheumatoid arthritis therapy after tumor necrosis factor and interleukin-1 blockade

Kurt Redlich¹, Georg Schett, Günter Steiner, Silvia Hayer, Erwin F Wagner, Josef S Smolen

Affiliations

PMID: 14673982
DOI: 10.1002/art.11358

Review

Rheumatoid arthritis therapy after tumor necrosis factor and interleukin-1 blockade

Kurt Redlich et al. Arthritis Rheum. 2003 Dec.

. 2003 Dec;48(12):3308-19.

doi: 10.1002/art.11358.

Authors

Kurt Redlich¹, Georg Schett, Günter Steiner, Silvia Hayer, Erwin F Wagner, Josef S Smolen

Affiliation

¹ University of Vienna, Vienna, Austria.

PMID: 14673982
DOI: 10.1002/art.11358

No abstract available

PubMed Disclaimer

Similar articles

[Redefining treatment of rheumatic arthritis with anti-cytokines].
Gabay C, So A. Gabay C, et al. Rev Med Suisse. 2007 Mar 21;3(103):715-7. Rev Med Suisse. 2007. PMID: 17458148 French. No abstract available.
The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis.
Cohen SB. Cohen SB. Rheum Dis Clin North Am. 2004 May;30(2):365-80, vii. doi: 10.1016/j.rdc.2004.01.005. Rheum Dis Clin North Am. 2004. PMID: 15172046 Review.
Results of anakinra treatment in rheumatoid arthritis patients previously treated with tumor necrosis factor alpha blockade: comment on the article by Buch et al.
Saxne T, Larsson L, Geborek P. Saxne T, et al. Arthritis Rheum. 2004 Sep;50(9):3049-50; author reply 3050-1. doi: 10.1002/art.20640. Arthritis Rheum. 2004. PMID: 15457477 No abstract available.
Lack of response to anakinra in rheumatoid arthritis following failure of tumor necrosis factor alpha blockade: comment on the article by Buch et al.
Schiff MH. Schiff MH. Arthritis Rheum. 2005 Jan;52(1):364-5; author reply 365. doi: 10.1002/art.20769. Arthritis Rheum. 2005. PMID: 15641081 No abstract available.
How antirheumatic drugs protect joints from damage in rheumatoid arthritis.
Schett G, Stach C, Zwerina J, Voll R, Manger B. Schett G, et al. Arthritis Rheum. 2008 Oct;58(10):2936-48. doi: 10.1002/art.23951. Arthritis Rheum. 2008. PMID: 18821703 Review. No abstract available.

See all similar articles

Cited by

To switch or to change class-the biologic dilemma in rheumatoid arthritis.
Villeneuve E, Haraoui B. Villeneuve E, et al. Nat Rev Rheumatol. 2010 May;6(5):301-5. doi: 10.1038/nrrheum.2010.45. Epub 2010 Apr 13. Nat Rev Rheumatol. 2010. PMID: 20386564 Review.
Antifibrotic therapy in scleroderma: extracellular or intracellular targeting of activated fibroblasts?
Varga J. Varga J. Curr Rheumatol Rep. 2004 Apr;6(2):164-70. doi: 10.1007/s11926-004-0062-8. Curr Rheumatol Rep. 2004. PMID: 15016348 Review.
Osteoclastogenesis and arthritis.
Maruotti N, Grano M, Colucci S, d'Onofrio F, Cantatore FP. Maruotti N, et al. Clin Exp Med. 2011 Sep;11(3):137-45. doi: 10.1007/s10238-010-0117-2. Epub 2010 Nov 11. Clin Exp Med. 2011. PMID: 21069419 Review.
Modelling cost-effectiveness of biologic treatments based on disease activity scores for the management of rheumatoid arthritis in Spain.
Beresniak A, Ariza-Ariza R, Garcia-Llorente JF, Ramirez-Arellano A, Dupont D. Beresniak A, et al. Int J Inflam. 2011;2011:727634. doi: 10.4061/2011/727634. Epub 2011 Jun 28. Int J Inflam. 2011. PMID: 21785694 Free PMC article.
Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial.
Smolen J, Landewé RB, Mease P, Brzezicki J, Mason D, Luijtens K, van Vollenhoven RF, Kavanaugh A, Schiff M, Burmester GR, Strand V, Vencovsky J, van der Heijde D. Smolen J, et al. Ann Rheum Dis. 2009 Jun;68(6):797-804. doi: 10.1136/ard.2008.101659. Epub 2008 Nov 17. Ann Rheum Dis. 2009. PMID: 19015207 Free PMC article. Clinical Trial.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information